SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investor of AlloVir, Inc. – ALVR
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of AlloVir, Inc. (“AlloVir” or the “Company”) (NASDAQ: ALVR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether AlloVir and certain of its officers and/or directors have engaged in securities fraud or other unlawful … Read more
